Myelofibrosis Treatments
Find Myelofibrosis Treatments
Medications for Myelofibrosis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Myelofibrosis.
Found 2 Approved Drugs for Myelofibrosis
Inrebic
Generic Name
Fedratinib
Inrebic
Generic Name
Fedratinib
Form: Capsule
Method of administration: Oral
FDA approval date: August 16, 2019
INREBIC ® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). INREBIC is a kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) ( 1 ).
Vonjo
Generic Name
Pacritinib
Vonjo
Generic Name
Pacritinib
Form: Capsule
Method of administration: Oral
FDA approval date: February 28, 2022
Classification: Kinase Inhibitor
VONJO is indicated for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) with a platelet count below 50 × 10 9 /L. This indication is approved under accelerated approval based on spleen volume reduction [see Clinical Studies (1.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances